Omigapil
id:
omigapil-254-16033152
title:
Omigapil
text:
Omigapil is a drug that was developed by Novartis and tested in clinical trials for its ability to help treat Parkinson's disease (PD) and amyotrophic lateral sclerosis (ALS). The development for PD and ALS have been terminated due to lack of benefit, but Santhera Pharmaceuticals bought the compound for development for the treatment of congenital muscular dystrophy (CMD). Omigapil was first synthesized at Ciba-Geigy, Basel, Switzerland. Santhera Pharmaceuticals has since taken over production of
brand slug:
wiki
category slug:
encyclopedia
description:
Drug developed by Novartis
original url:
https://en.wikipedia.org/wiki/Omigapil
date created:
date modified:
2024-03-27T08:35:00Z
main entity:
{"identifier":"Q7090184","url":"https://www.wikidata.org/entity/Q7090184"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/5/58/Omigapil_skeletal.svg","width":203,"height":131}
fields total:
13
integrity:
15